More importantly, we found that GSK484 significantly inhibited tumor size, tumor weight and tumor volume in mice following irradiation.<h4>Conclusions</h4>PAD4 inhibitor GSK484 attenuated the radioresistance and cellular progression in NPC. The gene discussed is PADI4; the disease is nasopharyngeal carcinoma.